Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1993 Nov;348(5):515-9.
doi: 10.1007/BF00173212.

Azelastine and allergen transduction signal in MC9 mast cells

Affiliations

Azelastine and allergen transduction signal in MC9 mast cells

K Fanous et al. Naunyn Schmiedebergs Arch Pharmacol. 1993 Nov.

Abstract

MC9 mast cells, sensitized with monoclonal IgE antibody specific for 2,4-dinitrophenyl (DNP) group, were exposed to DNP-BSA and the pH and cytosolic calcium signals were recorded by using the fluorescent probes BCECF and Fura-2 respectively. DNP-BSA induced cell alkalinization was fully inhibited by azelastine with IC50 (1.6 +/- 0.5 mumol/l, mean +/- SEM, n = 5) similar to that required to inhibit histamine release (1.4 mumol/l). Conversely, high azelastine concentrations (> 100 mumol/l) were required to inhibit DNP-BSA-dependent cell calcium mobilization (IC50 approximately 200 mumol/l, n = 3). Amiloride, but not the H1 histamine antagonist pyrilamine, was able to inhibit the DNP-BSA induced pH signal. In acidified mast cells, azelastine potently inhibited Na+:H+ exchange activity (IC50 = 7.7 +/- 3.6 x 10(-6) M, mean +/- SEM, n = 3). Conversely, in mouse spleen lymphocytes azelastine was unable to inhibit the amiloride-sensitive pH signal induced by concanavalin A. In conclusion, the inhibition of histamine release by azelastine is not due to an interference with the cytosolic calcium signal. Conversely, azelastine potently antagonized the allergen-dependent Na+:H+ exchange activation, suggesting an action on the protein kinase C signaling pathway.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Agents Actions. 1989 Aug;28(1-2):9-15 - PubMed
    1. Physiol Rev. 1989 Apr;69(2):417-81 - PubMed
    1. J Biol Chem. 1987 Nov 5;262(31):15277-84 - PubMed
    1. Eur J Pharmacol. 1988 Mar 22;148(1):35-41 - PubMed
    1. Annu Rev Immunol. 1986;4:419-70 - PubMed

Publication types